This study describes the influence of apolipoproteins on the hepatic lipase (HL)-mediated hydrolysis of phospholipids and triacylglycerol in high density lipoproteins (HDL). HL-mediated hydrolysis was assessed in well characterized, homogeneous preparations of spherical reconstituted high density lipoproteins (rHDL).
Hepatic lipase (HL)1 is a 476-amino acid glycoprotein of molecular weight 64,000 -69,000 (1) that is bound to liver sinusoidal endothelial cells (2). HL hydrolyzes acyl ester bonds of triacylglycerol and the sn-1 acyl ester bond of phospholipids. The main plasma substrates for HL are very low density lipoproteins and high density lipoproteins (HDL). The role of HL in HDL metabolism is of considerable importance, as shown by strong negative associations between HL activity and plasma HDL 2 levels (3-5) and the dramatic reduction in the HDL levels of rabbits that have been made transgenic for human HL (6). Unlike lipoprotein lipase (LPL), which requires apolipoprotein C-II (apoC-II) for maximal activity, there is no known protein cofactor for HL. However, there is some conflicting evidence to suggest that the apoA-II in HDL may influence the HL-mediated hydrolysis of triacylglycerol in HDL (7-10). Some investigators have reported that apoA-II enhances (7, 8), while others have concluded that it inhibits, the HL-mediated hydrolysis of triacylglycerol in HDL (9, 10).The present study was carried out in order to determine whether there are significant differences in the HL-mediated hydrolysis of phospholipids and triacylglycerol in HDL that differ in their apolipoprotein composition. This has been achieved by using well defined, homogeneous preparations of spherical reconstituted HDL (rHDL) as substrates for HL. The rHDL were comparable in size and lipid composition and contained either apoA-I or apoA-II as their sole apolipoprotein constituent. The results show that apolipoproteins not only have a major influence on the HL-mediated hydrolysis of the triacylglycerol and phospholipids in rHDL but also regulate the affinity of HL for the rHDL surface.
EXPERIMENTAL PROCEDURESPurification of ApoA-I and ApoA-II-ApoA-I and apoA-II were prepared from pooled human plasma donated by the Transfusion Service, Royal Adelaide Hospital. HDL were isolated from the plasma by sequential ultracentrifugation in the 1.07 Ͻ d Ͻ 1.21 g/ml density range (11). The isolated HDL were delipidated (12), and the resulting apoHDL was subjected to anion exchange chromatography on Q Sepharose Fast Flow (Amersham Pharmacia Biotech, Uppsala, Sweden) (13). The purified apoA-I and apoA-II appeared as single bands following electrophoresis on a homogeneous 20% SDS-polyacrylamide PhastGel (Amersham Pharmacia Biotech) and Coomassie staining.